16A Stock Chart & Stats
€1.73
€0.25(13.51%)
At close: 4:00 PM EDT
€1.73
€0.25(13.51%)
Day’s Range― - ―
52-Week Range€1.26 - €3.24
Previous CloseN/A
Volume0.00
Average Volume (3M)68.00
Market Cap
€837.53M
Enterprise Value€5.42B
Total Cash (Recent Filing)€217.70M
Total Debt (Recent Filing)€4.26B
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Nov 03, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.52
Shares Outstanding639,664,000
10 Day Avg. Volume0
30 Day Avg. Volume68
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.69Price Target Upside55.49% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.65
Revenue Forecast (FY)€2.04B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue MixA higher recurring-revenue mix should improve predictability, retention and cash-flow visibility because more sales come from subscription-like relationships. This supports a steadier operating base and gives Clarivate a stronger platform for cross-selling software, data and workflow modules over the next several quarters.
Cash Generation And Debt ReductionConsistently positive operating and free cash flow gives Clarivate internal funding capacity despite reported losses. Using that cash, along with divestiture proceeds, to reduce debt can lower interest burden and improve financial flexibility, strengthening the balance sheet for future investment and execution.
AI Product TractionEarly customer adoption and a multimillion-dollar pipeline indicate that Clarivate’s AI products are moving beyond development into commercial use. Embedding AI into proprietary research and IP data can deepen product differentiation, support premium workflows and create additional recurring growth opportunities.
Bears Say
Persistent Revenue ContractionShrinking revenue shows that Clarivate’s growth recovery is not yet broad-based, even though recurring organic growth has improved. Continued top-line pressure can limit operating leverage, make reinvestment harder and increase reliance on cost actions or portfolio disposals to sustain earnings progress.
Ongoing Net LossesPersistent bottom-line losses indicate that improved EBITDA and adjusted earnings have not yet translated into durable GAAP profitability. The impairment amplified the latest loss, but the broader pattern still limits retained capital, weakens shareholder returns and leaves less tolerance for execution setbacks.
Meaningful LeverageDebt reduction is constructive, but leverage remains meaningful relative to equity and continues to constrain financial flexibility. Ongoing obligations can absorb cash that might otherwise fund product development or growth, while continued negative returns on equity show that the balance sheet is not yet producing attractive shareholder outcomes.
Clarivate News
16A FAQ
What was Clarivate’s price range in the past 12 months?
Clarivate lowest stock price was €1.26 and its highest was €3.24 in the past 12 months.
What is Clarivate’s market cap?
Clarivate’s market cap is €837.53M.
When is Clarivate’s upcoming earnings report date?
Clarivate’s upcoming earnings report date is Nov 03, 2026 which is in 24 days.
How were Clarivate’s earnings last quarter?
Clarivate released its earnings results on Jul 29, 2026. The company reported €0.169 earnings per share for the quarter, beating the consensus estimate of €0.161 by €0.008.
Is Clarivate overvalued?
According to Wall Street analysts Clarivate’s price is currently Undervalued.
Does Clarivate pay dividends?
Clarivate does not currently pay dividends.
What is Clarivate’s EPS estimate?
Clarivate’s EPS estimate is 0.16.
How many shares outstanding does Clarivate have?
Clarivate has 639,664,000 shares outstanding.
What happened to Clarivate’s price movement after its last earnings report?
Clarivate reported an EPS of €0.169 in its last earnings report, beating expectations of €0.161. Following the earnings report the stock price went up 13.514%.
Which hedge fund is a major shareholder of Clarivate?
Currently, no hedge funds are holding shares in DE:16A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€2.69 (55.49% Upside)
€2.69 (55.49% Upside)
Blogger Sentiment
Bullish
DE:16A Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Sold Shares
Worth €2.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.30%
12-Months-Change
Fundamentals
Return on Equity
-7.00%
Trailing 12-Months
Asset Growth
-8.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Clarivate
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
16A Company Deck
16A Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized clear progress on strategic priorities—AI product launches with early commercial traction, margin expansion, debt reduction and a higher-quality recurring revenue mix driven by portfolio rationalization. These positives were tempered by near-term headwinds including a large non-cash impairment related to the LS&H divestiture, transactional revenue declines, one-time transaction costs that depress free cash flow this year, and FX impacts. Management presented a credible path to sequential organic growth and profitability improvement in the second half, with stronger recurring revenue mix and disciplined capital allocation supporting confidence in longer-term execution.View all DE:16A earnings summaries16A Stock 12 Month Forecast
Average Price Target
€2.69
▲(55.49% Upside)
Technical Analysis
Accenture
―
Exlservice Holdings
―
Gartner
―
Genpact
―
International Business Machines
―